Estimating the occurrence of false positives and false negatives in microarray studies by approximating and partitioning the empirical distribution of p-valuesPOUNDS, Stan; MORRIS, Stephan W.Bioinformatics (Oxford. Print). 2003, Vol 19, Num 10, pp 1236-1242, issn 1367-4803, 7 p.Article

Inhibition of the Insulin-like Growth Factor-1 Receptor (IGF1R) Tyrosine Kinase as a Novel Cancer Therapy ApproachRONGSHI LI; POURPAK, Alan; MORRIS, Stephan W et al.Journal of medicinal chemistry (Print). 2009, Vol 52, Num 16, pp 4981-5004, issn 0022-2623, 24 p.Article

Role for MKL1 in megakaryocytic maturationCHENG, Ee-Chun; QING LUO; YI SUN et al.Blood. 2009, Vol 113, Num 12, pp 2826-2834, issn 0006-4971, 9 p.Article

ALK⁺ CD30⁺ lymphomas : A distinct molecular genetic subtype of non-Hodgkin's lymphomaMORRIS, Stephan W; XUE, Liquan; ZHIGUI MA et al.British journal of haematology. 2001, Vol 113, Num 2, pp 275-295, issn 0007-1048Article

A liaison dangereuse between AUF1/hnRNPD and the oncogenic tyrosine kinase NPM-ALK. CommentaryMORRIS, Stephan W; FAWAL, Mohamad; ARMSTRONG, Florence et al.Blood. 2006, Vol 108, Num 8, issn 0006-4971, 2500-2501,2780-2788 [11 p.]Article

Loss of SHP1 enhances JAK3/STAT3 signaling and decreases proteosome degradation of JAK3 and NPM-ALK in ALK⁺ anaplastic large-cell lymphoma. CommentaryMORRIS, Stephan W; YAJUN HAN; AMIN, Hesham M et al.Blood. 2006, Vol 108, Num 8, issn 0006-4971, 2500-2501,2796-2803 [10 p.]Article

Diversity of genomic breakpoints in TFG-ALK translocations in anaplastic large cell lymphomas: Identification of a new TFG-ALK_XL chimeric gene with transforming activityHERNANDEZ, Luis; BEA, Silvia; MASON, David et al.The American journal of pathology. 2002, Vol 160, Num 4, pp 1487-1494, issn 0002-9440Article

Nucleophosmin-anaplastic lymphoma kinase of anaplastic large-cell lymphoma recruits, activates, and uses pp60^c-src to mediate its mitogenicityCUSSAC, Daniel; GREENLAND, Catherine; ROCHE, Serge et al.Blood. 2004, Vol 103, Num 4, pp 1464-1471, issn 0006-4971, 8 p.Article

ALK-positive plasmablastic B-cell lymphoma with expression of the NPM-ALK fusion transcript: report of 2 casesONCIU, Mihaela; BEHM, Frederick G; DOWNING, James R et al.Blood. 2003, Vol 102, Num 7, pp 2642-2644, issn 0006-4971, 3 p.Article

Anaplastic lymphoma kinase (ALK) expression in the inflammatory myofibroblastic tumor : A comparative immunohistochemical studyCOOK, James R; DEHNER, Louis P; COLLINS, Margaret H et al.The American journal of surgical pathology. 2001, Vol 25, Num 11, pp 1364-1371, issn 0147-5185Article

Nucleophosmin-anaplastic lymphoma kinase associated with anaplastic large-cell lymphoma activates the phosphatidylinositol 3-kinase/Akt antiapoptotic signaling pathwayBAI, Ren-Yuan; TAO OUYANG; MIETHING, Cornelius et al.Blood. 2000, Vol 96, Num 13, pp 4319-4327, issn 0006-4971Article

Design and synthesis of a novel tyrosine kinase inhibitor templateJAKE SLAVISH, P; QIN JIANG; XIAOLI CUI et al.Bioorganic & medicinal chemistry. 2009, Vol 17, Num 9, pp 3308-3316, issn 0968-0896, 9 p.Article

Synthetic mRNA Splicing Modulator Compounds with in Vivo Antitumor ActivityLAGISETTI, Chandraiah; POURPAK, Alan; GORONGA, Tinopiwa et al.Journal of medicinal chemistry (Print). 2009, Vol 52, Num 22, pp 6979-6990, issn 0022-2623, 12 p.Article

Antitumor Compounds Based on a Natural Product Consensus PharmacophoreLAGISETTI, Chandraiah; POURPAK, Alan; QIN JIANG et al.Journal of medicinal chemistry (Print). 2008, Vol 51, Num 19, pp 6220-6224, issn 0022-2623, 5 p.Article

The oncogenic fusion protein nucleophosmin-anaplastic lymphoma kinase (NPM-ALK) induces two distinct malignant phenotypes in a murine retroviral transplantation modelMIETHING, Cornelius; GRUNDLER, Rebekka; FEND, Falco et al.Oncogene (Basingstoke). 2003, Vol 22, Num 30, pp 4642-4647, issn 0950-9232, 6 p.Article

Expression of the oncogenic NPM-ALK chimeric protein in human lymphoid T-cells inhibits drug-induced, but not Fas-induced apoptosisGREENLAND, Catherine; TOURIOL, Christian; CHEVILLARD, Grégory et al.Oncogene (Basingstoke). 2001, Vol 20, Num 50, pp 7386-7397, issn 0950-9232Article

Design and synthesis of 5-aryl-pyridone-carboxamides as inhibitors of anaplastic lymphoma kinaseRONGSHI LI; LIQUAN XUE; MCGRATH, Doug et al.Journal of medicinal chemistry (Print). 2006, Vol 49, Num 3, pp 1006-1015, issn 0022-2623, 10 p.Article

Role of phosphatidylinositol 3-kinase-akt pathway in nucleophosmin/anaplastic lymphoma kinase-mediated lymphomagenesisSLUPIANEK, Artur; NIEBOROWSKA-SKORSKA, Margaret; HOSER, Grazyna et al.Cancer research (Baltimore). 2001, Vol 61, Num 5, pp 2194-2199, issn 0008-5472Article

Role of signal transducer and activator of transcription 5 in nucleophosmin/ anaplastic lymphoma kinase-mediated malignant transformation of lymphoid cellsNIEBOROWSKA-SKORSKA, Malgorzata; SLUPIANEK, Artur; XUE, Liquan et al.Cancer research (Baltimore). 2001, Vol 61, Num 17, pp 6517-6523, issn 0008-5472Article

Fusion of the ALK gene to the clathrin heavy chain gene, CLTC, in inflammatory myofibroblastic tumorBRIDGE, Julia A; KANAMORI, Masahiko; MORRIS, Stephan W et al.The American journal of pathology. 2001, Vol 159, Num 2, pp 411-415, issn 0002-9440Article

Fusion of two novel genes, RBM15 and MKL1, in the t(1;22)(p13;q13) of acute megakaryoblastic leukemiaZHIGUI MA; MORRIS, Stephan W; KANEKO, Yasuhiko et al.Nature genetics. 2001, Vol 28, Num 3, pp 220-221, issn 1061-4036Article

Translocations involving anaplastic lymphoma kinase (ALK)DUYSTER, Justus; BAI, Ren-Yuan; MORRIS, Stephan W et al.Oncogene (Basingstoke). 2001, Vol 20, Num 40, pp 5623-5637, issn 0950-9232Article

Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase: Functions and genetic interactions in learning, memory and adult neurogenesisWEISS, Joseph B; CHANGHUI XUE; BENICE, Ted et al.Pharmacology, biochemistry and behavior. 2012, Vol 100, Num 3, pp 566-574, issn 0091-3057, 9 p.Article

Synthesis of an aryloxy oxo pyrimidinone library that displays ALK-selective inhibitionSLAVISH, P. Jake; PRICE, Jeanine E; QIN JIANG et al.Bioorganic & medicinal chemistry letters (Print). 2011, Vol 21, Num 15, pp 4592-4596, issn 0960-894X, 5 p.Article

Eμ-BCL10 mice exhibit constitutive activation of both canonical and noncanonical NF-κB pathways generating marginal zone (MZ) B-cell expansion as a precursor to splenic MZ lymphomaZHAOYANG LI; HONGSHENG WANG; REHG, Jerold E et al.Blood. 2009, Vol 114, Num 19, pp 4158-4168, issn 0006-4971, 11 p.Article